Keyphrases
Cardiovascular Prevention
100%
Mechanistic Insight
100%
Antithrombotic Therapy
100%
Factor Xa Inhibitors
100%
Pleiotropic Effects
100%
Atherothrombosis
100%
Mechanistic Implication
100%
Endothelial Dysfunction
40%
Platelets
40%
Physiological Condition
40%
Vascular Inflammation
40%
Thrombin
40%
Factor Xa
40%
Coagulation Proteases
40%
Myocardial Infarction
20%
Cardiovascular Morbidity
20%
Ischemic Stroke
20%
Peripheral Arterial Disease
20%
Oxidative Stress
20%
Immune Activation
20%
Cardiovascular Mortality
20%
Receptor Signaling
20%
Recent Advances
20%
Pathological Conditions
20%
Chronic Inflammatory Diseases
20%
Plaque Instability
20%
Vessel Wall
20%
Hypercoagulability
20%
Thrombus Formation
20%
Thromboembolism
20%
Coagulation Factors
20%
Atherogenesis
20%
Vascular Integrity
20%
Thrombosis
20%
Hemostasis
20%
Coagulation
20%
Protease-activated Receptor 1 (PAR1)
20%
Vascular Smooth muscle Cells
20%
Advanced Stage
20%
Fibrin Clot
20%
Plasma Coagulation
20%
Coagulation System
20%
Direct Oral Anticoagulants
20%
Thromboinflammation
20%
Atherothrombotic
20%
Cell Activation
20%
Vascular Biology
20%
Cardiovascular Therapy
20%
Factor VIIa
20%
Vascular Smooth muscle Cell Function
20%
Plaque Rupture
20%
Coagulation Enzyme
20%
Acute Cardiovascular Events
20%
Wall Components
20%
Endothelial Cell Dysfunction
20%
Vascular Protection
20%
Dual Pathway Inhibition
20%
Vasoprotective
20%
Formation Factor
20%
Plaque Erosion
20%
Major Adverse Limb Events
20%
INIS
inhibition
100%
inflammation
100%
atherosclerosis
100%
diseases
66%
muscles
66%
thrombin
66%
therapy
33%
arteries
33%
walls
33%
drugs
33%
mortality
33%
receptors
33%
blood
33%
myocardial infarction
33%
morbidity
33%
reviews
33%
vessels
33%
thrombosis
33%
protection
33%
erosion
33%
enzymes
33%
ischemia
33%
biology
33%
instability
33%
plasma
33%
oxidation
33%
limbs
33%
ruptures
33%
anticoagulants
33%
fibrin
33%
Medicine and Dentistry
Cardiovascular System
100%
Prothrombinase
100%
Thrombosis
100%
Antithrombotic
100%
Atherosclerosis
50%
Endothelial Dysfunction
33%
Thrombin
33%
Platelet
33%
Blood Clotting
33%
Proteinase
33%
Vasculitis
33%
Cell Activation
33%
Vascular Smooth Muscle Cell
33%
Oxidative Stress
16%
Endothelial Cell
16%
Immunocompetent Cell
16%
Clinical Study
16%
Myocardial Infarction
16%
Blood Clotting Factor
16%
Inflammatory Disorder
16%
Limb
16%
Cell Function
16%
Arteriosclerosis Obliterans
16%
Fibrin Clot
16%
Atherogenesis
16%
Brain Ischemia
16%
Hypercoagulability
16%
Blood Stasis
16%
Thromboembolism
16%
Vascular Biology
16%
Proteinase Activated Receptor
16%
Direct Oral Anticoagulant
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Blood Clotting Factor 10a
100%
Thrombosis
100%
Atherosclerosis
50%
Endothelial Dysfunction
33%
Thrombin
33%
Proteinase
33%
Vasculitis
33%
Thromboembolism
16%
Clinical Study
16%
Inflammatory Disease
16%
Brain Ischemia
16%
Peripheral Occlusive Artery Disease
16%
Blood Clotting Factor
16%
Thrombus
16%
Preclinical Study
16%
Heart Infarction
16%
Blood Stasis
16%
Atherogenesis
16%
Direct Oral Anticoagulant
16%
Proteinase Activated Receptor
16%
Hypercoagulability
16%